These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 390480)

  • 21. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
    Thiele J; Kvasnicka HM
    Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of polycythemia vera based on bone marrow pathology.
    Thiele JM; Kvasnicka HM
    Curr Hematol Rep; 2005 May; 4(3):218-23. PubMed ID: 15865875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bone marrow in myeloproliferative and dysmyelopoietic syndromes.
    Wolf BC; Neiman RS
    Hematol Oncol Clin North Am; 1988 Dec; 2(4):669-94. PubMed ID: 3065324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
    Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
    Swolin B; Rödjer S; Westin J
    Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
    Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
    Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
    Marchioli R; Finazzi G; Landolfi R; Kutti J; Gisslinger H; Patrono C; Marilus R; Villegas A; Tognoni G; Barbui T
    J Clin Oncol; 2005 Apr; 23(10):2224-32. PubMed ID: 15710945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow biopsy in polycythaemia vera.
    Krasznai G; Nagy G; Rácz M
    Acta Med Acad Sci Hung; 1969; 26(4):309-16. PubMed ID: 5380803
    [No Abstract]   [Full Text] [Related]  

  • 32. [Myeloid leukemia with myelofibrosis (author's transl)].
    Duhamel G; Gorin NC; Najaman A; André R
    Nouv Rev Fr Hematol; 1975; 15(1):99-105. PubMed ID: 126427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological alterations in bone marrow in patients with late engraftment after autologous bone marrow transplantation.
    Annaloro C; Oriani A; Pozzoli E; Deliliers DL; Bertolli VG; Volpe AD; Soligo D; Deliliers GL
    Bone Marrow Transplant; 2000 Apr; 25(8):837-41. PubMed ID: 10808204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera].
    Bai J; Xue YP; Ye L; Yao JF; Zhou CL; Qian LS; Yang RC; Li HY; Zhang HY; Shao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):685-8. PubMed ID: 18399175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome.
    Barbui T; Thiele J; Passamonti F; Rumi E; Boveri E; Randi ML; Bertozzi I; Marino F; Vannucchi AM; Pieri L; Rotunno G; Gisslinger H; Gisslinger B; Müllauer L; Finazzi G; Carobbio A; Gianatti A; Ruggeri M; Nichele I; D'Amore E; Rambaldi A; Tefferi A
    Blood; 2012 Mar; 119(10):2239-41. PubMed ID: 22246040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Quantitation of myelofibrosis in blood diseases by electronic image analysis (author's transl)].
    Goasguen J; Mignot J; Quennehen F; Ferrand B; Le Prise PY; Leblay R; Guérin D; Richier JL
    Nouv Rev Fr Hematol (1978); 1979; 21(1):17-29. PubMed ID: 290975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary (essential) thrombocythemia versus polycythemia vera rubra. A histomorphometric analysis of bone marrow features in trephine biopsies.
    Thiele J; Zankovich R; Schneider G; Kremer B; Fischer R; Diehl V
    Anal Quant Cytol Histol; 1988 Oct; 10(5):375-82. PubMed ID: 3207462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone-marrow biopsy in chronic myeloid leukemia. Significance during development].
    Devred C; Bentata J; Diebold J; Bernadou A; Bilski-Pasquier G
    Sem Hop; 1977 Jan; 53(2):125-31. PubMed ID: 189425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations.
    Barraco D; Cerquozzi S; Hanson CA; Ketterling RP; Pardanani A; Gangat N; Tefferi A
    Blood Cancer J; 2017 Mar; 7(3):e538. PubMed ID: 28282034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute myeloid leukemia with megakaryocytic predominance and malignant megakaryocyte proliferation. Apropos of 3 cases].
    Nigro M; Ascari E; Compagnoni A; Menestrina F
    Ann Anat Pathol (Paris); 1979; 24(2):171-84. PubMed ID: 294156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.